180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market
Holding ATNF?
Track your performance easily

180 Life Sciences (ATNF) Financial Statements

242 Followers

180 Life Sciences Financial Overview

180 Life Sciences's market cap is currently ―. The company's EPS TTM is $-28.486; its P/E ratio is -0.07; 180 Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 23.14K$ 2.77M$ -1.22M$ -12.60M$ -3.67M
EBITDA$ 305.49K$ 2.79M$ -1.20M$ -12.57M-
Net Income Common Stockholders$ 11.78K$ -1.07M$ -1.23M$ -10.00M$ -3.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.15M$ 675.98K$ 1.98M$ 2.66M$ 2.01M
Total Assets$ 3.91M$ 3.44M$ 5.26M$ 4.96M$ 13.67M
Total Debt$ 442.29K$ 788.88K$ 1.05M$ 355.10K$ 614.53K
Net Debt$ -704.00K$ 112.90K$ -921.74K$ -2.31M$ -1.39M
Total Liabilities$ 4.33M$ 4.40M$ 5.39M$ 5.11M$ 6.95M
Stockholders Equity$ -417.99K$ -954.47K$ -127.73K$ -149.33K$ 6.72M
Cash Flow-
Free Cash Flow$ 727.17K$ -1.03M$ -2.16M$ -1.78M-
Operating Cash Flow$ 727.17K$ -1.03M$ -2.16M$ -1.78M-
Investing Cash Flow-----
Financing Cash Flow$ -264.91K$ -264.39K$ 1.47M$ 2.45M-
Currency in USD

180 Life Sciences Earnings and Revenue History

180 Life Sciences Debt to Assets

180 Life Sciences Cash Flow

180 Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis